![]() | Study programme 2025-2026 | Français | |
![]() | Pharmacie clinique, Conseil et suivi pharmaceutique, Bonnes pratiques officinales, Pharmaco-économie | ||
Programme component of Master's in Pharmacy (MONS) (day schedule)Faculty of Medicine, Pharmacy and Biomedical Sciences |
| Code | Type | Head of UE | Department’s contact details | Teacher(s) |
|---|---|---|---|---|
| UM-M2-PHARMA-002-M | Compulsory UE | PATRIS Stéphanie | M110 - Pharmacie Clinique |
|
| Language of instruction | Language of assessment | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Credits | Weighting | Term |
|---|---|---|---|---|---|---|---|---|---|
| Français | 29 | 16 | 0 | 0 | 0 | 5 | 5.00 | 1st term |
| AA Code | Teaching Activity (AA) | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Term | Weighting |
|---|---|---|---|---|---|---|---|---|
| M-PCLI-201 | Pharmacie clinique et bonnes pratiques officinales | 24 | 0 | 0 | 0 | 0 | Q1 | |
| M-PCLI-236 | Soins pharmaceutiques (conseil et suivi pharmaceutique) | 0 | 15 | 0 | 0 | 0 | Q1 | |
| M-DOYM-237 | Pharmaco-économie | 5 | 1 | 0 | 0 | 0 | Q1 |
| Programme component |
|---|
Objectives of Programme's Learning Outcomes
Learning Outcomes of UE
At the end of this teaching unit based on lectures, discussions and simulations in an educational pharmacy, the student will be able to
- Apply the pharmaceutical care approach in community pharmacy and hospital pharmacy
- Provide patient-centered pharmaceutical care
- To check the adequacy of the treatment taking into account the characteristics of the patient
- To make choices taking into account the pharmaco-economy
- To conduct a support interview "Good Use of Medicines"
- To adopt a quality approach (quality management, quality measurement, self-control, etc.)
- To carry out an medication review of the elderly patient with polypharmacy
UE Content: description and pedagogical relevance
Clinical pharmacy and good pharmacy practices
Pharmaceutical care (pharmaceutical advice and follow-up)
Pharmaco-economy
Prior Experience
Not applicable
Type(s) and mode(s) of Q1 UE assessment
Q1 UE Assessment Comments
Clinical pharmacy and good pharmacy practices:
written exam (open questions) which assesses the knowledge and ability to use the concepts seen in the course.
Pharmaceutical care (pharmaceutical advice and follow-up):
Presence at sessions at the pedagogical pharmacy and PC room (seminars) is compulsory. The student must count at least 75% of attendance at seminars. ANY absence must be justified. e-learning is compulsory
participation : 20%
reports / personal works: 80%
Pharmaco-economy:
Written work
Method of calculating the overall mark for the Q1 UE assessment
If all AAs have a score greater than or equal to 10/20:
Clinical pharmacy and good pharmacy practices; 5/9
Pharmaceutical care (pharmaceutical advice and follow-up): 3/9
Pharmaco-economy: 1/9
If at least one AA has a score below 10/20: the EU score will be the lowest AA score.
Type(s) and mode(s) of Q1 UE resit assessment (BAB1)
Q1 UE Resit Assessment Comments (BAB1)
not applicable
Method of calculating the overall mark for the Q1 UE resit assessment
not applicable
Type(s) and mode(s) of Q3 UE assessment
Q3 UE Assessment Comments
Clinical pharmacy and good pharmacy practices:
written exam (open questions) which assesses the knowledge and ability to use the concepts seen in the course.
Pharmaceutical care (pharmaceutical advice and follow-up):
Presence at sessions at the pedagogical pharmacy (seminars) is compulsory. The student must count at least 75% of attendance at seminars. ANY absence must be justified
participation (from Q1) : 20%
reports / personal works: 80%
Pharmaco-economy:
Written work
Method of calculating the overall mark for the Q3 UE assessment
If all AAs have a score greater than or equal to 10/20:
Clinical pharmacy and good pharmacy practices; 5/9
Pharmaceutical care (pharmaceutical advice and follow-up): 3/9
Pharmaco-economy: 1/9
If at least one AA has a score below 10/20: the EU score will be the lowest AA score.
Type of Teaching Activity/Activities
| AA | Type of Teaching Activity/Activities |
|---|---|
| M-PCLI-201 |
|
| M-PCLI-236 |
|
| M-DOYM-237 |
|
Mode of delivery
| AA | Mode of delivery |
|---|---|
| M-PCLI-201 |
|
| M-PCLI-236 |
|
| M-DOYM-237 |
|
Required Learning Resources/Tools
| AA | Required Learning Resources/Tools |
|---|---|
| M-PCLI-201 | Documents on Moodle |
| M-PCLI-236 | Documents on Moodle |
| M-DOYM-237 | Not applicable |
Recommended Learning Resources/Tools
| AA | Recommended Learning Resources/Tools |
|---|---|
| M-PCLI-201 | Not applicable |
| M-PCLI-236 | Not applicable |
| M-DOYM-237 | Not applicable |
Other Recommended Reading
| AA | Other Recommended Reading |
|---|---|
| M-PCLI-201 | Not applicable |
| M-PCLI-236 | Not applicable |
| M-DOYM-237 | Cleemput I, Neyt M, Van de Sande S, Thiry N. Belgian guidelines for economic evaluations and budget impact analyses : second edition. Health Technology Assessment (HTA) Brussels : Belgian Health Care Knowledge Centre (KCE) : 2012. KCE report 183C. D/212/10.273/54 |